About this episode
John Stone, MD, MPH, is the world leader in the field of IgG4-related disease research. In this episode, he breaks down the histology of IgG4-related disease, important aspects of what is known about the pathophysiology of the disease, as well as future directions in treatment.
- Intro :10
- Inside this episode :13
- IgG4-related disease background :31
- An anecdote 1:15
- The interview 4:09
- History of IgG4-related disease 4:18
- IgG4 pathology and terms 7:48
- What makes IgG4 different from other IgG subclasses? 10:23
- What do we know about the interplay between B and T cells? 12:31
- What is SLAMF7? 16:30
- What happens to T cells during B-cell depletion? 18:22
- Antigens involved in IgG4 21:06
- Future of treatment 23:10
- Thank you, Dr. Stone 24:32
We'd love to hear from you! Send your comments/questions to [email protected]. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum
John Stone, MD, MPH, is director of clinical rheumatology at Massachusetts General Hospital.
Get every episode summarized
Each time Healio Rheuminations publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Healio Rheuminations

Healio Community Book Club: A conversation between Leonard Calabrese, DO and Kev...
Healio Rheuminations

Celebrating 101 episodes of Healio Rheuminations with Dr. Leonard Calabrese
Healio Rheuminations

The history of giant cell arteritis: Infections, injections and the man who coul...
Healio Rheuminations

The Unnecessarily Complex Story of Rheumatoid Factor
Healio Rheuminations